Case Study VolitionRx Underscores the Critical Role of Cybersecurity in the Fight Against Cancer VolitionRx Industry: Healthcare Location: United Kingdom Product: BlackBerry ® Protect Deployment: 115 endpoints Website: www.volition.com Author’s Note: BlackBerry completed its acquisition of Cylance on February 21, 2019, and is currently selling the CylancePROTECT ® solution under the newly rebranded name BlackBerry ® Protect. All references to the Cylance organization and its branded products and services in this case study utilize BlackBerry branding. Modern cancer diagnoses often involve expensive, unpleasant, and invasive testing. VolitionRx Limited was founded with a single goal in mind – helping to ensure that this is no longer the case. By diagnosing a ran

Join for free to read